Epirubicin and cyiclophosphamide (EC) versus docetaxel followed by EC in adjuvant treatment of node positive breast cancer. A multicenter randomized phase III study (GOIM9902)M. Lopez,M. Brandi,P. Foggi,F. Giotta,N. Gebbia,M. R. Valerio,B. Massidda, A. M. Carta,G. Filippelli, V. Olivito,G. Cicero,F. Schittulli, C. Floris,L. Di Martino,S. Corsetti,P. Vici,G. ColucciANNALS OF ONCOLOGY(2006)引用 0|浏览27暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络